PODCAST-19: FiveThirtyEight on the Novel Coronavirus
Een podcast door FiveThirtyEight, Anna Rothschild
46 Afleveringen
-
Pandemics Don't Really End
Gepubliceerd: 14-7-2021 -
How The CDC's Blindspots Complicated The Fight Against COVID-19
Gepubliceerd: 30-6-2021 -
The Lab Leak Commotion
Gepubliceerd: 2-6-2021 -
Who Should Decide Who Gets To Make COVID-19 Vaccines?
Gepubliceerd: 22-5-2021 -
How To Make Sure Your Kid Isn't A Superspreader
Gepubliceerd: 7-5-2021 -
You Might Have Given The Coronavirus To Your Cat
Gepubliceerd: 28-4-2021 -
What A Donated Vaccine Can Do
Gepubliceerd: 22-4-2021 -
The Johnson & Johnson Pause Shows The System Is Working
Gepubliceerd: 13-4-2021 -
What The Heck Is Going On With AstraZeneca's Vaccine?
Gepubliceerd: 26-3-2021 -
How To Overcome Vaccine Hesitancy
Gepubliceerd: 22-3-2021 -
The COVID-19 Endemic
Gepubliceerd: 6-3-2021 -
How Variants Complicate Everything
Gepubliceerd: 19-2-2021 -
The Ethical Dilemmas Prompted By The Vaccine Rollout
Gepubliceerd: 5-2-2021 -
What Happens Once You Get An mRNA Vaccine
Gepubliceerd: 15-1-2021 -
Answering All (Or At Least Some) Of Your Vaccine Questions
Gepubliceerd: 7-1-2021 -
The Dr. Fauci Holiday Special
Gepubliceerd: 22-12-2020 -
Why Emily Oster Made Her Own COVID-19 Database
Gepubliceerd: 11-12-2020 -
How To Trust That A COVID-19 Vaccine Is Safe
Gepubliceerd: 21-11-2020 -
There's No Longterm Plan For Long COVID
Gepubliceerd: 13-11-2020 -
What To Make Of Pfizer's Big Vaccine Announcement
Gepubliceerd: 10-11-2020
FiveThirtyEight's COVID-19 podcast is laser-focused on evidence. What do we know about the novel coronavirus, and what do we know we don't know? COVID-19 has pushed Americans into more uncertain territory than most have ever known. Our podcast helps listeners understand what they can be certain about, and what is still unknown. We investigate coronavirus mysteries, debate when it's safe to reopen the economy and keep track of the latest scientific developments on vaccines and treatments. We do it all with FiveThirtyEight's trademark blend of transparency and rigor.
